| Scrip Code | 541400 |
|---|---|
| NSE Symbol | ZIMLAB |
| MSEI Symbol | NOTLISTED |
| ISIN | INE518E01015 |
| Name of company | ZIM Laboratories Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 06-08-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 31-07-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | First quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Segment Reporting | Single segment |
| Description of single segment | Pharmacuetical Industry |
| Start date and time of board meeting | 06-08-2026 10:30:00 |
| End date and time of board meeting | 06-08-2026 16:30:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| 1. This note pertains to column asking for No. of times funds raised during the quarter. We would like to inform you that the Company has raised the funds through prefrential issue in the previous quarter ended 31st March 2026 and no funds were raised during the current quater ended 30th June 2026. As there is no option to select 0 or Not applicable for this quater and this being the mandatory field, we have selected the no. of times fund raised for this quarter as 1. However, no funds were raised for the reporting quarter. 2. The disclosure for the Default on Loan and Debt Securities is not applicable for the said reporting period. | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | 9,304.83 | 9,304.83 | |
| Other income | 98.55 | 98.55 | |
| Total income | 9,403.38 | 9,403.38 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 4,381.61 | 4,381.61 |
| (b) | Purchases of stock-in-trade | 50.91 | 50.91 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (485.87) | (485.87) |
| (d) | Employee benefit expense | 1,813.69 | 1,813.69 |
| (e) | Finance costs | 364.34 | 364.34 |
| (f) | Depreciation, depletion and amortisation expense | 517.08 | 517.08 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 3,303.84 | 3,303.84 |
| Total other expenses | 3,303.84 | 3,303.84 | |
| Total expenses | 9,945.60 | 9,945.60 | |
| 3 | Total profit before exceptional items and tax | (542.22) | (542.22) |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | (542.22) | (542.22) |
| 6 | Tax expense | ||
| 7 | Current tax | 0.00 | 0.00 |
| 8 | Deferred tax | (154.67) | (154.67) |
| 9 | Total tax expenses | (154.67) | (154.67) |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (387.55) | (387.55) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | (387.55) | (387.55) |
| 17 | Other comprehensive income net of taxes | (2.45) | (2.45) |
| 18 | Total Comprehensive Income for the period | (390.00) | (390.00) |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 5,354.90 | 5,354.90 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -0.72 | -0.72 | |
| Diluted earnings (loss) per share from continuing operations | -0.72 | -0.72 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -0.72 | -0.72 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -0.72 | -0.72 | |
| 24 | Debt equity ratio | 0.5100 | 0.5100 |
| 25 | Debt service coverage ratio | 0.5200 | 0.5200 |
| 26 | Interest service coverage ratio | -0.4900 | -0.4900 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Notes : 1) The above statement of standalone financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 05 August 2026 and 06 August 2026. The above results have been subjected to limited review by Statutory Auditor of the Company. 2) These financial results have been prepared in accordance with the recognition and measurement principles of applicable Indian Accounting Standard ('Ind AS') notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended), as prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations and guidelines issued by the Securities and Exchange Board of India (SEBI). 3) The figures for the quarter ended 31 March 2026 are the balancing figures between the audited figures for the year ended 31 March 2026 and year to date figures upto 31 December 2025, on which auditors had performed a limited review. 4) The Company is principally engaged in a single business segment which is pharmaceuticals. There is no separate reportable segment as per Ind AS 108 - Operating Segments. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Measurement of defined employee benefit plans | (3.46) | (3.46) |
| Total Amount of items that will not be reclassified to profit and loss | (3.46) | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (1.01) | (1.01) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | (2.45) | (2.45) |
| Mode of Fund Raising | Preferential Issues |
|---|---|
| Description of mode of fund raising (Applicable in case of others is selected) | |
| Date of Raising Funds | 13-03-2026 |
| Amount Raised | 34,99,99,949.62 |
| Report filed for Quarter ended | 30-06-2026 |
| Monitoring Agency | Not Applicable |
| Monitoring Agency Name, if applicable | |
| Is there a Deviation / Variation in use of funds raised | No |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | |
| If Yes, Date of shareholder Approval | |
| Explanation for the Deviation / Variation | |
| Comments of the Audit Committee after review | |
| Comments of the auditors, if any |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | 0 | 0 | 0.00 | 0.00 | 0.00 | 0.00 | This is to inform that the Company has raised funds through preferential issue during the previous quarter ended 31st March 2026. Company has not raised any funds during the reporting quater ended 30th June, 2026 and in this quarter there is no deviation or Variation in the utilisation of the fund raised. |
| Name of signatory | Piyush Nikhade |
| Designation of person | Company Secretary and Compliance Officer |
| Place | Nagpur |
| Date | 06-08-2026 |